Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Check source scope before reading a dose
Zevtera - labeled renal guidance
Product / population
Ceftobiprole medocaril sodium (Zevtera), IV injection
Renal guidance: 2.3 Recommended Dosage Regimen in Adult Patients with Renal Impairment / 2.4 Recommended Dosage Regimen for CABP in Pediatric Patients (2 Years to Less than 18 Years Old) with Renal Impairment
For adults use the IV label's renal table when CrCl is below 50 mL/min. Select dose and interval for the indication and phase of treatment; use the HD instructions on dialysis days. Pediatric adjustments use indexed eGFR and age-specific criteria. Confirm ceftobiprole medocaril sodium versus active ceftobiprole when reading doses.
RDM74-zevtera-official-1 · Source locator: Renal guidance: 2.3 Recommended Dosage Regimen in Adult Patients with Renal Impairment / 2.4 Recommended Dosage Regimen for CABP in Pediatric Patients (2 Years to Less than 18 Years Old) with Renal Impairment
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.
